Advanced Corporate Finance

Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies.

Available at: https://www.cnbc.com/2019/01/03/bristol-myers-squibb- shares-fall-on-74-billion-celgene-acquisition.html. (accessed 18th August, 2020).

Question:

Evaluate and provide two (2) main reasons with evidence which cause the failure/success of the merger and acquisition.